Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer Academic Article uri icon

Overview

MeSH Major

  • Antiphospholipid Syndrome
  • Autoantibodies
  • Immunoassay
  • Lupus Erythematosus, Systemic

abstract

  • CAI is a potential agent for additional study in the stabilization of relapsed ovarian cancer. Given a limited toxicity profile, it may have utility as a maintenance therapeutic agent for this disease.

publication date

  • January 2004

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.3109/14733400410001689306

Additional Document Info

start page

  • 4356

end page

  • 63

volume

  • 4

number

  • 1